AI Automated Translation.

Font Size

Share

LG Chem announces 2027 executive reshuffle, promotes Kim Mu-yong and Kim Sang-min to vice presidents

LG Chem announces 2027 executive reshuffle, promotes Kim Mu-yong and Kim Sang-min to vice presidents

Kim Sang-min (left), head of the Petrochemical Business Division, and Kim Mu-yong, CEO of Pharmhanong. /Photo provided by LG Chem
Kim Sang-min (left), head of the Petrochemical Business Division, and Kim Mu-yong, CEO of Pharmhanong. /Photo provided by LG Chem

LG Chem announced on the 19th that it has executed its 2027 executive promotion appointments for a total of 14 individuals, including the promotions of Kim Mu-yong, CEO of Pharmhanong, and Kim Sang-min, head of the Petrochemical Business Division, to vice president.

The appointments consist of two promotions to vice president, two promotions to senior executive vice president, nine new appointments to executive director, and one new appointment as chief research fellow (executive director). The focus was on accelerating the transition into a materials company with strong customer-centric technology in response to rapidly changing business environments, and securing a foundation for sustainable growth through portfolio innovation and strengthening future R&D (research and development) competitiveness.

LG Chem stated, "We selected talent to lead improved business operations and market response capabilities from a customer perspective based on thorough performance-based management, qualitative strengthening of the portfolio and high-value-added transformation of existing businesses, and securing differentiated future technology competitiveness." The company added, "Through this, we plan to proactively respond to customer demand and elevate our business structure centered on high value-added products."

Newly appointed Vice President Kim Mu-yong was named head of the Life Sciences Business Division. Vice President Kim is an expert with a deep understanding of new drug development processes, as well as pharmaceutical business management strategy and operational capabilities. He has served in roles including Head of Life Sciences Management Strategy, Head of the SD (Specialty Drug) Business Unit, and Head of the Primary Care Business Unit. Since December 2022, he has served as CEO of Pharmhanong, leading efforts to improve profitability in the green bio business, strengthen the foundation for global growth, and identify future growth drivers.

Newly appointed Vice President Kim Sang-min will continue to serve as head of the Petrochemical Business Division. Vice President Kim has accumulated experience in strategy, new business development, M&A (mergers and acquisitions), and business operations at various companies within the group, including LG Chem and LG Corp. Since his appointment as head of the Petrochemical Business Division in December 2024, he has been recognized for driving fundamental improvements in the business by expanding the share of high-value-added businesses and improving cost structures, thereby laying the foundation for restoring competitiveness in the petrochemical sector.

Senior Executive Vice President Shim Gyu-seok was appointed head of the Advanced Materials Business Division. Senior Executive Vice President Shim has accumulated extensive experience in R&D, strategy and planning, and production, having served as Head of the ABS (high-value-added synthetic resin) Business Unit and Head of the HPM (high-performance resin) Business Unit. Since December 2025, he has served as CTO (Chief Technology Officer), contributing to improving the company-wide R&D structure and strengthening future competitiveness. He was appointed head of the Advanced Materials Business Division in recognition of his combined business operations experience and R&D expertise.

Lee Chung-hoon, who was promoted to senior executive vice president, was appointed as the new CTO. He is currently Head of the NCC (naphtha cracking facility)/PO (polyolefin) Business Unit. Senior Executive Vice President Lee is an expert with 22 years of R&D experience in the PO field. He has led product and process innovation and future technology development, and was appointed Head of the NCC/PO Business Unit in December 2023. Since then, he has been recognized for contributing to profitability improvements through next-generation product development and portfolio elevation.

Ko Gyeong-deok, Head of the Electronic Materials Business Unit, was also promoted to senior executive vice president. Senior Executive Vice President Ko has been responsible for strategy and planning, marketing, and new business operations in the fields of display, semiconductor, and next-generation mobility materials. Since his appointment as Head of the Electronic Materials Business Unit in December 2024, he has been recognized for improving the profitability of existing businesses and cultivating growth businesses such as semiconductor materials, solar control films (SCF) for vehicles, and adhesives.

Executive Director Choi Hak-yong was appointed CEO (Chief Executive Officer) of Pharmhanong. Executive Director Choi has accumulated experience in chemical products and agricultural food businesses at global companies such as BASF, and joined Pharmhanong in 2022 as Head of Overseas Business. He subsequently contributed to expanding overseas operations and identifying new business opportunities, and is expected to lead the elevation and globalization of Pharmhanong's business going forward.

"This article was translated using AI and may differ slightly from the original."